Toward a clinical framework for crosslinked hyaluronic acid lip augmentation

Background: Lip augmentation with crosslinked hyaluronic acid is often framed as a volumizing procedure; however, clinical performance is shaped by material properties, tissue mechanics, vascular anatomy, and injection strategy. Objective: This review synthesizes selected literature into a clinically applicable framework for product selection and conservative treatment planning in lip augmentation. Methods: The discussion was organized around biomaterial design, dynamic tissue behavior, vascular safety, and pharmacobiological reversibility. A de-identified illustrative case was retained only to contextualize the framework and was not used as confirmatory evidence. Results: Across the literature, outcomes appear to depend less on injected volume alone than on the fit among gel properties, anatomical precision, tissue mobility, and preparedness for complication management. Lip-specific rheology, structure-property relationships, ultrasound-informed safety, and responsiveness to hyaluronidase emerge as key determinants of predictable performance. The evidence base remains limited by product heterogeneity, uneven lip-specific data, and insufficiently standardized follow-up. In the illustrative case, conservative subunit-based treatment with 1.0 mL of crosslinked hyaluronic acid improved contour definition, projection, and upper-to-lower lip proportion at 15 days without observed vascular compromise. Conclusion: Current evidence supports a conservative, anatomy-aware, biomaterial-centered approach to lip augmentation while underscoring the need for stronger comparative studies and more standardized outcome assessment.